Back to search

Article

Cholesteryl Ester as a Prognostic Biomarker In IDH-wildtype Glioblastoma

2026-05-08

Abstract excerpt

Current treatment of IDH-wildtype glioblastoma (GBM) relies on the first-line chemotherapy-temozolomide. Although MGMT methylation is routinely conducted to predict chemosensitivity, its efficacy is often compromised. Thus, there is an urgent need to discover more accurate prognostic biomarkers. Cholesteryl ester (CE) has been recently recognized as a key feature of GBM, however, its role in GBM prognosis remains...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
19378e80-c335-54ad-8fdb-7d6f73f22b08
DOI
10.64898/2026.05.05.722825
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Select a neighboring publication to make it the new centre.